首頁 > 市場調查報告書 > 製藥

癌症

南美洲和中美洲膠質瘤治療市場預測至 2030 年 - 區域分析 - 按疾病、治療類型、等級和最終用戶

市場調查報告書

商品編碼

1452590

南美洲和中美洲膠質瘤治療市場預測至 2030 年 - 區域分析 - 按疾病、治療類型、等級和最終用戶

South & Central America Glioma Treatment Market Forecast to 2030 - Regional Analysis - by Disease, Treatment Type, Grade, and End User

出版日期: 2024年01月15日 | 出版商:

The Insight Partners | 英文 82 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

南美洲和中美洲神經膠質瘤治療市場預計將從2022年的1.1714億美元成長到2030年的2.2774億美元。預計2022年至2030年CAGR為8.7%。

新興經濟體增加的機會推動南美洲和中美洲神經膠質瘤治療市場

巴西、俄羅斯、印度、中國和南非（金磚國家）是世界上成長最快的經濟體之一。這些國家以及其他發展中經濟體的醫療保健產業預計將在未來幾年迅速擴張。預期成長歸因於客戶需求的變化、醫療保健服務意識的提高以及人口老化的持續成長。隨著醫療保健產業的蓬勃發展，全球腦癌診斷市場可能在未來幾年顯著成長。此外，政府在醫療保健設施上的支出增加和消費者購買力有助於發展中國家醫療保健產業的成長。

在 COVID-19 疫情爆發前 20 年，美洲地區的醫療服務覆蓋率有所改善，儘管進展緩慢。與 2000 年 65% 的人相比，2019 年 77% 的人擁有健康保險。政府衛生支出增加1.1個百分點，衛生人員數量增加。因此，該地區不斷成長的醫療保健產業為神經膠質瘤治療市場參與者創造了擴大業務的機會。

南美洲和中美洲神經膠質瘤治療市場概述

南美洲和中美洲的神經膠質瘤治療市場分為巴西、阿根廷以及南美洲和中美洲的其他地區。該地區的市場成長歸因於腦癌發病率的上升和醫療保健系統發展的刺激。此外，拉丁美洲國家的大學正在與各種私人和上市公司合作，以支持與腦癌治療相關的研究。人們對神經血管疾病的認知不斷提高也有利於南美洲和中美洲的神經膠質瘤治療市場。

根據世界資料.info，巴西是世界上面積和人口第五大的國家，並且正在經歷最快的人口老化。根據 Globocan 2020 報告，腦癌是巴西最常見的死亡原因。 2020 年，巴西報告了 12,260 例新發腦癌病例，腦癌和中樞神經系統癌症導致 10,920 人死亡。此外，巴西所有年齡層的腦癌 5 年盛行率為每 10 萬人約 15.17 例。阿根廷的癌症病例數正在穩定成長。根據世界衛生組織全球癌症觀察站發布的Globocan報告，2020年阿根廷新診斷約1,831例腦癌病例，其中1,488人因腦癌死亡。阿根廷各年齡層腦癌的 5 年盛行率為每 10 萬人口 11.62 例。

智利、哥倫比亞、秘魯、古巴、委內瑞拉和玻利維亞是南美洲和中美洲神經膠質瘤治療市場的主要貢獻者。這些國家正在透過允許新的市場參與者進入市場來改善其醫療保健基礎設施。此外，南美洲和中美洲其他國家正在投資並有興趣改善其醫療保健研究活動並採用先進的腦癌療法。

南美洲和中美洲膠質瘤治療市場收入及 2030 年預測（百萬美元）

南美洲和中美洲神經膠質瘤治療市場細分

南美洲和中美洲神經膠質瘤治療市場按疾病、治療類型、等級、最終用戶和國家細分。

根據疾病，南美洲和中美洲神經膠質瘤治療市場分為星狀細胞瘤、少突星狀細胞瘤和少突膠質細胞瘤。 2022 年，星狀細胞瘤細分市場在南美洲和中美洲神經膠質瘤治療市場中佔據最大佔有率。

依治療類型，南美洲和中美洲膠質瘤治療市場分為手術、化療、放射治療等。 2022 年，手術細分市場在南美洲和中美洲神經膠質瘤治療市場中佔最大佔有率。

根據級別，南美洲和中美洲神經膠質瘤治療市場分為低級別和高級別。 2022 年，高層級細分市場在南美洲和中美洲神經膠質瘤治療市場中佔有更大佔有率。

根據最終用戶，南美洲和中美洲神經膠質瘤治療市場分為醫院和診所以及門診手術中心。 2022 年，醫院和診所部門在南美洲和中美洲神經膠質瘤治療市場中佔有更大佔有率。

根據國家/地區，南美洲和中美洲神經膠質瘤治療市場分為巴西、阿根廷以及南美洲和中美洲其他地區。 2022 年，巴西在南美洲和中美洲神經膠質瘤治療市場佔據主導地位。

Amgen Inc、Biocon Ltd、F. Hoffmann-La Roche Ltd、Merck & Co Inc、Pfizer Inc、Sun Pharmaceutical Industries Ltd 和 Teva Pharmaceutical Industries Ltd 是南美洲和中美洲神經膠質瘤治療市場上的一些領先公司。

Brazil, Russia, India, China, and South Africa (BRICS) are among the fastest-growing economies in the world. The healthcare sectors in these countries, as well as other developing economies, are projected to expand rapidly in the coming years. The expected growth is ascribed to changes in customer demand, an increase in awareness about healthcare services, and a continuous rise in the aging population. The global brain cancer diagnostics market is likely to grow significantly in the coming years with the proliferation of the healthcare sector. Further, increased government spending on healthcare facilities and consumer purchasing power contribute to the growth of the healthcare sector in developing countries.

20 years before the COVID-19 epidemic, health service coverage in the Americas region improved, albeit slowly. Compared to 65% of people in 2000, 77% of people in 2019 had health insurance. Government spending on health expanded by 1.1 percentage points while the number of health personnel increased. Thus, the growing healthcare sector in the region creates opportunities for the glioma treatment market players to expand their business.

South & Central America Glioma Treatment Market Overview

The glioma treatment market in South & Central America is segmented into Brazil, Argentina, and the Rest of South & Central America. The market growth in this region is ascribed to the rising incidence of brain cancer and a spur in developments in healthcare systems. In addition, the universities in Latin American countries are collaborating with various private and public companies to support studies related to brain cancer treatment. The rising awareness about neurovascular disorders is also favoring the glioma treatment market in South & Central America.

Brazil is the fifth largest country in the world by area and population and is experiencing the fastest demographic aging as per the world data.info. As per the Globocan 2020 report, brain cancer is the most common cause of death in Brazil. 12,260 new cases of brain cancer were reported in Brazil in 2020, while brain and CNS cancers led to 10,920 deaths. Further, the 5-year prevalence rate of brain cancer in Brazil for all ages is ~15.17 per 100,000 population. The number of cancer cases in Argentina is increasing at a steady rate. According to the Globocan report published by the Global Cancer Observatory of the WHO, ~1,831 new cases of brain cancer were diagnosed in 2020, of which 1,488 deaths were reported due to brain cancer in Argentina. The 5-years prevalence rate of brain cancer for all age groups was found to be 11.62 per 100,000 population in Argentina.

Chile, Colombia, Peru, Cuba, Venezuela, and Bolivia are among other the key contributors to the glioma treatment market in South & Central America. These countries are improving their healthcare infrastructure by allowing new market players to enter into the marketplace. In addition, the countries in the Rest of South & Central America are investing and taking an interest in improving their healthcare research activities and adopting advanced therapies for brain cancer.

South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Million)

South & Central America Glioma Treatment Market Segmentation

The South & Central America glioma treatment market is segmented into disease, treatment type, grade, end user, and country.

Based on disease, the South & Central America glioma treatment market is segmented into astrocytoma, oligoastrocytoma, and oligodendroglioma. The astrocytoma segment held the largest share of the South & Central America glioma treatment market in 2022.

Based on treatment type, the South & Central America glioma treatment market is segmented into surgery, chemotherapy, radiation therapy, and others. The surgery segment held the largest share of the South & Central America glioma treatment market in 2022.

Based on grade, the South & Central America glioma treatment market is segmented into low grade and high grade. The high grade segment held a larger share of the South & Central America glioma treatment market in 2022.

Based on end user, the South & Central America glioma treatment market is segmented into hospital & clinics and ambulatory surgical center. The hospital & clinics segment held a larger share of the South & Central America glioma treatment market in 2022.

Based on country, the South & Central America glioma treatment market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America glioma treatment market in 2022.

Amgen Inc, Biocon Ltd, F. Hoffmann-La Roche Ltd, Merck & Co Inc, Pfizer Inc, Sun Pharmaceutical Industries Ltd, and Teva Pharmaceutical Industries Ltd are some of the leading companies operating in the South & Central America glioma treatment market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. South & Central America Glioma Treatment Market - Key Industry Dynamics

4.1 Market Drivers
- 4.1.1 High Incidence Rate of Brain Cancer in South America
- 4.1.2 Increase in Prevalence of High-Grade Glioma
4.2 Key Market Restraints
- 4.2.1 High Cost of Diagnosis
4.3 Key Market Opportunities
- 4.3.1 Advancements in Healthcare Sector in Emerging Economies
4.4 Future Trends
- 4.4.1 Surge in Drug Approvals for Glioma Treatment
4.5 Impact Analysis:

5. Glioma Treatment Market - South & Central America Market Analysis

5.1 South & Central America Glioma Treatment Market Revenue (US$ Mn), 2022 - 2030

6. South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 - by Disease

6.1 Overview
6.2 South & Central America Glioma Treatment Market Revenue Share, by Disease 2022 & 2030 (%)
6.3 Astrocytoma
- 6.3.1 Overview
- 6.3.2 Astrocytoma: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Oligoastrocytoma
- 6.4.1 Overview
- 6.4.2 Oligoastrocytoma: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Oligodendroglioma
- 6.5.1 Overview
- 6.5.2 Oligodendroglioma: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)

7. South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 - by Treatment Type

7.1 Overview
7.2 South & Central America Glioma Treatment Market Revenue Share, by Treatment Type 2022 & 2030 (%)
7.3 Surgery
- 7.3.1 Overview
- 7.3.2 Surgery: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Chemotherapy
- 7.4.1 Overview
- 7.4.2 Chemotherapy: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Radiation Therapy
- 7.5.1 Overview
- 7.5.2 Radiation Therapy: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Others
- 7.6.1 Overview
- 7.6.2 Others: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)

8. South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 - by Grade

8.1 Overview
8.2 South & Central America Glioma Treatment Market Revenue Share, by Grade 2022 & 2030 (%)
8.3 Low Grade
- 8.3.1 Overview
- 8.3.2 Low Grade: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.1 Grade I: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.2 Grade II: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.4 High Grade
- 8.4.1 Overview
- 8.4.2 High Grade: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.4.2.1 Grade III: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.4.2.2 Grade IV: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)

9. South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 - by End User

9.1 Overview
9.2 South & Central America Glioma Treatment Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Hospital & Clinics
- 9.3.1 Overview
- 9.3.2 Hospital & Clinics: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Ambulatory Surgical Centers
- 9.4.1 Overview
- 9.4.2 Ambulatory Surgical Centers: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)

10. South & Central America Glioma Treatment Market - Country Analysis

10.1 South & Central America Glioma Treatment Market, Revenue and Forecast to 2030
- 10.1.1 Overview
  - 10.1.1.1 South & Central America Glioma Treatment Market, by Country
  - 10.1.1.2 Brazil
    - 10.1.1.2.1 Brazil: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.1.1.2.2 Brazil: South & Central America Glioma Treatment Market, by Disease
    - 10.1.1.2.3 Brazil: South & Central America Glioma Treatment Market, by Treatment Type
    - 10.1.1.2.4 Brazil: South & Central America Glioma Treatment Market, by Grade
    - 10.1.1.2.4.1 Brazil: South & Central America Glioma Treatment Market, by Low Grade
    - 10.1.1.2.4.2 Brazil: South & Central America Glioma Treatment Market, by High Grade
    - 10.1.1.2.5 Brazil: South & Central America Glioma Treatment Market, by End User
  - 10.1.1.3 Argentina
    - 10.1.1.3.1 Argentina: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.1.1.3.2 Argentina: South & Central America Glioma Treatment Market, by Disease
    - 10.1.1.3.3 Argentina: South & Central America Glioma Treatment Market, by Treatment Type
    - 10.1.1.3.4 Argentina: South & Central America Glioma Treatment Market, by Grade
    - 10.1.1.3.4.1 Argentina: South & Central America Glioma Treatment Market, by Low Grade
    - 10.1.1.3.4.2 Argentina: South & Central America Glioma Treatment Market, by High Grade
    - 10.1.1.3.5 Argentina: South & Central America Glioma Treatment Market, by End User
  - 10.1.1.4 Rest of South & Central America
    - 10.1.1.4.1 Rest of South & Central America: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.1.1.4.2 Rest of South & Central America: South & Central America Glioma Treatment Market, by Disease
    - 10.1.1.4.3 Rest of South & Central America: South & Central America Glioma Treatment Market, by Treatment Type
    - 10.1.1.4.4 Rest of South & Central America: South & Central America Glioma Treatment Market, by Grade
    - 10.1.1.4.4.1 Rest of South & Central America: South & Central America Glioma Treatment Market, by Low Grade
    - 10.1.1.4.4.2 Rest of South & Central America: South & Central America Glioma Treatment Market, by High Grade
    - 10.1.1.4.5 Rest of South & Central America: South & Central America Glioma Treatment Market, by End User

11. Glioma Treatment Market Industry Landscape

11.1 Overview
11.2 Growth Strategies Done by the Companies in the Market, (%)
11.3 Organic Developments
- 11.3.1 Overview
11.4 Inorganic Developments
- 11.4.1 Overview

12. Company Profiles

12.1 F. Hoffmann-La Roche Ltd
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Merck & Co Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Sun Pharmaceutical Industries Ltd
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Amgen Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Teva Pharmaceutical Industries Ltd
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Pfizer Inc
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Biocon Ltd
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments

13. Appendix

13.1 About Us
13.2 Glossary of Terms

簡介目錄圖表

List Of Tables

Table 1. South & Central America Glioma Treatment Market Segmentation
Table 2. Brazil: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
Table 3. Brazil: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
Table 4. Brazil: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
Table 5. Brazil: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
Table 6. Brazil: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
Table 7. Brazil: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
Table 8. Argentina: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
Table 9. Argentina: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
Table 10. Argentina: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
Table 11. Argentina: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Low Grade
Table 12. Argentina: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - High Grade
Table 13. Argentina: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
Table 14. Rest of South & Central America: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
Table 15. Rest of South & Central America: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
Table 16. Rest of South & Central America: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
Table 17. Rest of South & Central America: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
Table 18. Rest of South & Central America: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
Table 19. Rest of South & Central America: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
Table 20. Organic Developments Done By Companies
Table 21. Inorganic Developments Done By Companies
Table 22. Glossary of Terms, glioma treatment market

List Of Figures

Figure 1. South & Central America Glioma Treatment Market Segmentation, By Country
Figure 2. South & Central America Glioma Treatment Market - Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. South & Central America Glioma Treatment Market Revenue (US$ Mn), 2022 - 2030
Figure 5. South & Central America Glioma Treatment Market Revenue Share, by Disease 2022 & 2030 (%)
Figure 6. Astrocytoma: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Oligoastrocytoma: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Oligodendroglioma: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. South & Central America Glioma Treatment Market Revenue Share, by Treatment Type 2022 & 2030 (%)
Figure 10. Surgery: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Chemotherapy: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Radiation Therapy: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Others: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. South & Central America Glioma Treatment Market Revenue Share, by Grade 2022 & 2030 (%)
Figure 15. Low Grade: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Grade I: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Grade II: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. High Grade: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Grade III: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Grade IV: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. South & Central America Glioma Treatment Market Revenue Share, by End User 2022 & 2030 (%)
Figure 22. Hospital & Clinics: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Ambulatory Surgical Centers: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. South & Central America Glioma Treatment Market, By Country, 2022 ($Mn)
Figure 25. South & Central America Glioma Treatment Market, By Key Countries, 2022 And 2030 (%)
Figure 26. Brazil: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 27. Argentina: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 28. Rest of South & Central America: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 29. Growth Strategies Done by the Companies in the Market, (%)